Amedisys

Home Healthcare Market to Value USD 786.85 Billion by 2032 | Precedence Research

Retrieved on: 
Thursday, November 23, 2023
Mohawk Valley Health System, Housekeeping, Elder abuse, Remote patient monitoring, Privacy, Risk, Ulcer, RPM, Patient, Physiology, Embarrassment, Universal Health Services, Memorial Hermann Health System, Hospice, Holding company, Bayada Home Health Care, DFU, NLP, USD, Stroke, Caregiver, Social media, Rehabilitation, Infection, United Kingdom Homecare Association, Ageing, JV, Home, Partnership, Growth, The Valley Hospital, Hospital, Palliative care, Digital health, Robotics, Contessa, Transport, Frailty, Residential care, Speciality chemicals, Health care, Amedisys

Smart Healthcare Products Market : The global market size is expected to be worth around USD 427.43 billion by 2032 from USD 142 billion in 2022 with a CAGR of 11.7% over the forecast period 2023 to 2032.

Key Points: 
  • Smart Healthcare Products Market : The global market size is expected to be worth around USD 427.43 billion by 2032 from USD 142 billion in 2022 with a CAGR of 11.7% over the forecast period 2023 to 2032.
  • Digital Health Market : The global market size was valued at USD 262.63 billion in 2022 and it is anticipated to surpass around USD 939.54 billion by 2032 with a CAGR of 13.1% from 2023 to 2032.
    eHealth Market : The global market size was valued at US$ 128.99 billion in 2022 and is expected to hit US$ 707.23 billion by 2032, poised to grow at a CAGR of 18.6% from 2023 to 2032.
    mHealth Market : The global market was valued at USD 80.61 billion in 2022 and is expected to reach over USD 269.31 billion by 2032 with a registered CAGR of 12.3% from 2023 to 2032.
  • Healthcare IT Market : The global market was estimated at USD 200 billion in 2022 and is expected to hit around USD 1069.13 billion by 2032, poised to grow at a CAGR of 18.30% from 2023 to 2032.
  • Electronic Health Records Market : The global electronic health records market was estimated at USD 25 billion in 2022 and is expected to hit around USD 39.38 billion by 2032, poised to grow at a CAGR of 4.70% from 2023 to 2032.

Home Healthcare Market to Value USD 786.85 Billion by 2032 | Precedence Research

Retrieved on: 
Thursday, November 23, 2023
Mohawk Valley Health System, Housekeeping, Elder abuse, Remote patient monitoring, Privacy, Risk, Ulcer, RPM, Patient, Physiology, Embarrassment, Universal Health Services, Memorial Hermann Health System, Hospice, Holding company, Bayada Home Health Care, DFU, NLP, USD, Stroke, Caregiver, Social media, Rehabilitation, Infection, United Kingdom Homecare Association, Ageing, JV, Home, Partnership, Growth, The Valley Hospital, Hospital, Palliative care, Digital health, Robotics, Contessa, Transport, Frailty, Residential care, Speciality chemicals, Health care, Amedisys

Smart Healthcare Products Market : The global market size is expected to be worth around USD 427.43 billion by 2032 from USD 142 billion in 2022 with a CAGR of 11.7% over the forecast period 2023 to 2032.

Key Points: 
  • Smart Healthcare Products Market : The global market size is expected to be worth around USD 427.43 billion by 2032 from USD 142 billion in 2022 with a CAGR of 11.7% over the forecast period 2023 to 2032.
  • Digital Health Market : The global market size was valued at USD 262.63 billion in 2022 and it is anticipated to surpass around USD 939.54 billion by 2032 with a CAGR of 13.1% from 2023 to 2032.
    eHealth Market : The global market size was valued at US$ 128.99 billion in 2022 and is expected to hit US$ 707.23 billion by 2032, poised to grow at a CAGR of 18.6% from 2023 to 2032.
    mHealth Market : The global market was valued at USD 80.61 billion in 2022 and is expected to reach over USD 269.31 billion by 2032 with a registered CAGR of 12.3% from 2023 to 2032.
  • Healthcare IT Market : The global market was estimated at USD 200 billion in 2022 and is expected to hit around USD 1069.13 billion by 2032, poised to grow at a CAGR of 18.30% from 2023 to 2032.
  • Electronic Health Records Market : The global electronic health records market was estimated at USD 25 billion in 2022 and is expected to hit around USD 39.38 billion by 2032, poised to grow at a CAGR of 4.70% from 2023 to 2032.

Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2023

Retrieved on: 
Wednesday, October 25, 2023
OPCH, Health, EDT, Nursing, Video game, Amedisys

BANNOCKBURN, Ill., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2023.

Key Points: 
  • BANNOCKBURN, Ill., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2023.
  • Option Care Health will host a conference call to discuss its third quarter 2023 financial results later today at 8:30 a.m. EDT.
  • The conference call can be accessed via a live audio webcast that will be available online at https://investors.optioncarehealth.com .
  • A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

Amedisys Reports Third Quarter 2023 Financial Results

Retrieved on: 
Tuesday, October 24, 2023
Physician, EBITDA, GAAP, Bank statement, UnitedHealth Group, Rehabilitation, Conditional sentence, Hospital, Depreciation, SNF, Patient, Hospice, Clothing, Pharmaceutical industry, Music, Bank, Amedisys

BATON ROUGE, La., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2023.

Key Points: 
  • BATON ROUGE, La., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2023.
  • Three-Month Periods Ended September 30, 2023 and 2022
    Net service revenue decreased $1.8 million to $556.2 million compared to $558.0 million in 2022.
  • Net loss attributable to Amedisys, Inc. per diluted share of $0.89 compared to net income attributable to Amedisys, Inc. per diluted share of $2.66 in 2022.
  • In light of the pending merger of the Company with UnitedHealth Group Incorporated, Amedisys will not conduct a quarterly earnings call to discuss the third quarter results.

Amedisys Celebrates National Quality Week

Retrieved on: 
Wednesday, October 18, 2023
National Association, HCI, Organization, Senior, Contessa, National Healthcare, Health, Palliative care, Patient, Patient safety, Hospice, CMS, Star, Nursing, Amedisys

During National Quality Week, Amedisys will focus on the importance of quality in healthcare by raising awareness among healthcare professionals and patients.

Key Points: 
  • During National Quality Week, Amedisys will focus on the importance of quality in healthcare by raising awareness among healthcare professionals and patients.
  • Amedisys Hospice outperformed the national average in all seven quality measures of the Hospice Item Set (HIS) in the CMS August 2023 preview report.
  • "National Quality Week provides us with a platform to showcase our unwavering dedication to quality and reinforces our commitment to delivering exceptional healthcare services to our patients.
  • Congratulations to our outstanding clinicians for their dedication to clinical distinction and quality.”
    The National Healthcare Quality Week was established by the National Association of Healthcare Quality in 1985, among other things, to recognize and celebrate the contribution of healthcare quality experts in their various organizations.

APCI to Feds: Stop Further Healthcare Vertical Integration in Optum-Amedisys Deal

Retrieved on: 
Thursday, October 19, 2023
Amedisys, Federal Trade Commission, PBM, Medicare Payment Advisory Commission, APCI, Section 5 of the Indian Limitation Act, Medicare, Congress, Texas Juvenile Justice Department, Federation, United States Congress, UnitedHealth Group, Federal Trade Commission Act of 1914, Acquisition, Optum, Justice minister, Justice, U.S. Department of Justice Office of Legislative Affairs, Health, Medicare Part D, Pharmacy, Office of Inspector General, U.S. Department of Health and Human Services, FTC, Pharmacist, Patient, Letter, DOJ, Dietary supplement, Health insurance

The acquisition represents a further descent into an already vertically integrated healthcare supply chain.

Key Points: 
  • The acquisition represents a further descent into an already vertically integrated healthcare supply chain.
  • "APCI has been one of the loudest and most consistent voices in opposing further vertical and horizontal integration by large insurers and their affiliated PBMs," said APCI CEO Tim Hamrick.
  • "Community pharmacists have seen first-hand what vertical integration has done in pharmacy and the burden it has caused patients.
  • APCI is committed to advocating on behalf of patients and the community pharmacies that serve them against further large insurer/PBM integration before agencies, U.S. Congress, and in the states."

Amedisys Recognizes Suicide Prevention Awareness Month and Promotes the 988 Suicide & Crisis Lifeline

Retrieved on: 
Thursday, August 31, 2023
Psychiatry, Organization, Mental health, Patient, Senior, Suicide, Nursing, Amedisys

In support of this important cause, Amedisys is highlighting the 988 Suicide and Crisis Lifeline which makes it easier for individuals in crisis to access crucial resources and assistance.

Key Points: 
  • In support of this important cause, Amedisys is highlighting the 988 Suicide and Crisis Lifeline which makes it easier for individuals in crisis to access crucial resources and assistance.
  • Suicide Prevention Awareness Month, observed annually in September, aims to raise awareness surrounding the devastating impact of suicide and the importance of mental health.
  • "During Suicide Prevention Awareness Month, Amedisys is proud to support initiatives, such as the 988 Suicide and Crisis Lifeline, that can make a real difference in people's lives," said Cyndi Shook, Senior Vice President of Clinical Services at Amedisys.
  • Amedisys encourages individuals to spread the word, educate themselves and others and take an active role in suicide prevention during Suicide Prevention Awareness Month and beyond.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DBTX, AMED, RETA, SURF

Retrieved on: 
Tuesday, August 29, 2023
Sale, Regeneron Pharmaceuticals, Fraud, Therapy, Advertising, Biogen, Security (finance), Amedisys, Optum, Decibel

If you are a Decibel shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Decibel shareholder, click here to learn more about your rights and options .
  • If you are an Amedisys shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

Moore Kuehn Encourages AMED, DBTX, RETA, and SURF Investors to Contact Law Firm

Retrieved on: 
Tuesday, August 29, 2023
Biogen, PLLC, Regeneron Pharmaceuticals, Wall Street, Fraud, Reata Pharmaceuticals, Therapy, Security (finance), Bank, Amedisys, Decibel

Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.

Key Points: 
  • Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.
  • Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq.
  • Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
  • Moore Kuehn is a 5-star Google client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims.

Moore Kuehn Encourages TRTN, CFMS, AMED, and NEX Investors to Contact Law Firm

Retrieved on: 
Wednesday, August 9, 2023
PLLC, Optum, Dipterocarpus conformis, Triton International, Wall Street, Patterson-UTI, Fraud, Brookfield Infrastructure Partners, Security (finance), Bank, Amedisys

Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.

Key Points: 
  • Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.
  • Under the proposed transaction, Triton International shareholders will receive $68.50 in cash and $16.50 in BIPC class A exchangeable shares per share.
  • Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq.
  • Moore Kuehn is a 5-star Google client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims.